AAME
Atlantic American Corporation
There isn't enough reported data to score AAME yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
AAME Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
AAME's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AAME.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
AAME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 4.3x | $1.19 | — |
| Cheap | 5.4x | $1.51 | +27% |
| Fair | 14x | $3.87 | +225% |
| Expensive | 34x | $9.41 | +690% |
Historical ranges are pointers, not guarantees.
AAME has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
AAME Forward outlook
There aren't enough analyst estimates for AAME to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
AAME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.28 | +$0.51 |
| Q3 2025 | $0.21 | +$0.56 |
| Q2 2025 | $0.09 | +$0.26 |
| Q1 2025 | -$0.10 | -$0.05 |
| Q4 2024 | -$0.23 | -$0.20 |
| Q3 2024 | -$0.35 | -350% |
| Q2 2024 | -$0.17 | -950% |
| Q1 2024 | -$0.05 | +$0.10 |
AAME has the stronger earnings trend. Trailing diluted EPS is up 22% for AAME versus JPM up 18%.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
AAME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $51.3M | +4.5% |
| Q3 2025 | $53.8M | +21% |
| Q2 2025 | $55.3M | +16% |
| Q1 2025 | $50.1M | +6.7% |
| Q4 2024 | $49M | +4.9% |
| Q3 2024 | $44.5M | -0.2% |
| Q2 2024 | $47.7M | -3.1% |
| Q1 2024 | $47M | +1.6% |
JPM has the stronger quarterly revenue trend. Revenue is up 4.5% for AAME versus up 8.1% for JPM.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 3.3% | +2.2 points |
| Q3 2025 | 1.4% | +6.9 points |
| Q2 2025 | 7.6% | +9.4 points |
| Q1 2025 | 2.1% | +7.4 points |
| Q4 2024 | 1.1% | +7.8 points |
| Q3 2024 | -5.5% | -10 points |
| Q2 2024 | -1.8% | -6.3 points |
| Q1 2024 | -5.3% | -1.4 points |
AAME's operating margin was 3.3% last quarter, up 2.2 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
AAME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $17.7M | +86% |
| Q3 2025 | $6.6M | +11298% |
| Q2 2025 | $9.1M | +2423% |
| Q1 2025 | -$986K | +$4.4M |
| Q4 2024 | $9.5M | +54% |
| Q3 2024 | $58K | -96% |
| Q2 2024 | $361K | -95% |
| Q1 2024 | -$5.4M | +$6.3M |
AAME has the stronger cash trend. Its trailing FCF is up 504% versus its history, compared with JPM at down 229%.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
AAME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1K shares |
| 1 year | 0% | -2K shares |
| 3 years | 0% | +8K shares |
| 5 years | -6.5% | -1.4M shares |
| Available history | -5.3% | -1.1M shares |
AAME has 20M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
| Q2 2019 | $22,000 |
| Q1 2019 | $49,000 |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over AAME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
AAME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -4.7x | Net Cash |
| Q3 2025 | -4.4x | Net Cash |
| Q2 2025 | -11.6x | Net Cash |
| Q4 2023 | -290.6x | Net Cash |
| Q3 2023 | -4.5x | Net Cash |
| Q2 2023 | -13.3x | Net Cash |
| Q4 2022 | -9.0x | Net Cash |
| Q3 2022 | -4.1x | Net Cash |
AAME has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like AAME.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
AAME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.3 | Neutral |
| Stochastic | 16.6 | Oversold |
AAME's weekly RSI is 37 (neutral) and its Stochastic is 17 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
AAME PE vs Financial Services Sector
| Metric | AAME | Sector median | Relative |
|---|---|---|---|
| PE | 4.3x | 13x | 67% below |
| PE % | 5 | 63 | 58 pts below |
AAME has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
AAME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.18 | 0.8% above |
| 20 week MA | $1.36 | 13% below |
| 50 week MA | $2.04 | 42% below |
| 100 week MA | $2.08 | 43% below |
| 200 week MA | $2.05 | 42% below |
AAME has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 42% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over AAME on trend strength, trading above more of its moving averages.
AAME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.85 | $2.08 | +12% |
| 2021 | $2.08 | $3.21 | +54% |
| 2022 | $3.21 | $2.42 | -25% |
| 2023 | $2.42 | $2.45 | +1.2% |
| 2024 | $2.45 | $1.48 | -40% |
| 2025 | $1.48 | $2.55 | +72% |
| 2026 YTD | $2.55 | $1.19 | -53% |
AAME is down 53% so far in 2026, after finishing higher in four of the previous six years.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over AAME on returns for 2026, with the stronger performance.